- Immunoassay
- On-site Testing
- Mass Spectrometry
- Others
Drug Abuse Testing (DAT) Market size is valued at USD 2332.84 million in 2023 and is expected to reach USD 2934.80 million by 2030, at a CAGR of 3.9% from 2024-2030. Drug abuse testing is frequently employed in forensic and clinical settings. Drug testing has increased in popularity in recent years and is frequently covered in the media. Drug testing is still done in athletics and sports today, but it is becoming more frequent in business, education, the military, retail, and public places. New technologies are being developed to speed up and improve the effectiveness of drug testing to meet the rising demand for such testing. Drug tests can now be administered on-site by certified personnel, with results being available in only a few minutes.
The rise in the number of clinical laboratories offering drug abuse testing services has contributed to the market's progress. The market for drug abuse testing services is also anticipated to benefit from a significant rise in the number of physician laboratories, hospital-based laboratories, retail clinics, and independent laboratories that collect samples and conduct drug screening tests. Drug abuse testing has increased over the past few years. An automated analyzer is used in a hospital laboratory to perform medical drug testing. The leading players in the market are acquiring or working with other companies to gain a more significant stake in the market as a result of the companies' growing interest in the industry.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
One of the key drivers for the drug abuse testing industry is the increase in the number of people who consume alcohol and illicit drugs such as marijuana, cocaine, and others. Furthermore, technological improvements in drug screening/testing equipment, as well as severe government regulations requiring drug screening, are propelling the market forward. However, in some countries, a lack of awareness and the perception of drug testing as a violation of personal rights limits the growth of the worldwide drug misuse testing market. Emerging markets such as Asia-Pacific and Latin America and the Caribbean (LAMEA) offer significant potential for the drug misuse testing business to expand.
The Drug Abuse Testing Market is projected to expand at a CAGR of 3.9% during the forecast period.
Abbott Laboratories, Danaher Corporation (Beckman Coulter), LabCorp, Dragerwerk AG & Co. KGaA, Quest Diagnostics Inc.
North America is the fastest-growing region for Drug Abuse Testing Market
1.Executive Summary |
2.Global Drug Abuse Testing Market Introduction |
2.1.Global Drug Abuse Testing Market - Taxonomy |
2.2.Global Drug Abuse Testing Market - Definitions |
2.2.1.Technology |
2.2.2.Sample Type |
2.2.3.Region |
3.Global Drug Abuse Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Drug Abuse Testing Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Drug Abuse Testing Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Immunoassay |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. On-site Testing |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Mass Spectrometry |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6.Global Drug Abuse Testing Market By Sample Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Urine |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Saliva |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Blood |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Hair |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Drug Abuse Testing Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8.North America Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Immunoassay |
8.1.2.On-site Testing |
8.1.3.Mass Spectrometry |
8.1.4.Others |
8.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Urine |
8.2.2.Saliva |
8.2.3.Blood |
8.2.4.Hair |
8.2.5.Others |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9.Europe Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Immunoassay |
9.1.2.On-site Testing |
9.1.3.Mass Spectrometry |
9.1.4.Others |
9.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Urine |
9.2.2.Saliva |
9.2.3.Blood |
9.2.4.Hair |
9.2.5.Others |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
10.Asia Pacific (APAC) Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Immunoassay |
10.1.2.On-site Testing |
10.1.3.Mass Spectrometry |
10.1.4.Others |
10.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Urine |
10.2.2.Saliva |
10.2.3.Blood |
10.2.4.Hair |
10.2.5.Others |
10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11.Middle East and Africa (MEA) Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Immunoassay |
11.1.2.On-site Testing |
11.1.3.Mass Spectrometry |
11.1.4.Others |
11.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Urine |
11.2.2.Saliva |
11.2.3.Blood |
11.2.4.Hair |
11.2.5.Others |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12.Latin America Drug Abuse Testing Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Immunoassay |
12.1.2.On-site Testing |
12.1.3.Mass Spectrometry |
12.1.4.Others |
12.2. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Urine |
12.2.2.Saliva |
12.2.3.Blood |
12.2.4.Hair |
12.2.5.Others |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Abbott Laboratories |
13.2.2.Danaher Corporation (Beckman Coulter) |
13.2.3.LabCorp |
13.2.4.Dragerwerk AG & Co. KGaA |
13.2.5.Quest Diagnostics Inc. |
13.2.6.Randox Testing Services |
13.2.7.United States Drug Testing Laboratories Inc. (USDTL) |
13.2.8.Thermo Fisher Scientific Inc. |
13.2.9.Siemens Healthineers AG |
13.2.10.Hoffmann-La Roche Ltd |
14. Research Methodology |
15. Appendix and Abbreviations |